Ocata Therapeutics (OCAT) Issued Patent Related to RPE Therapy for Macular Degenerative Diseases

June 2, 2015 8:12 AM EDT Send to a Friend
Ocata Therapeutics, Inc. (NASDAQ: OCAT) today announced that it continues to fortify the scope of protection covering its retinal pigment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login